Polevik I V, Karadzhaeva G B, Vaĭnshteĭn G B
Fiziol Zh SSSR Im I M Sechenova. 1990 Apr;76(4):467-72.
The changes of cerebrovascular reactivity (CVR) under influence of calcium antagonist nimodipine (0.01 and 0.06 mg/kg i.v.) and verapamil (0.6 and 1.0 mg/kg i.v.) were investigated in chronic experiments in 12 rabbits. Platinum electrodes were implanted into cortex, thalamus and hypothalamus, and cerebral blood flow was measured in these zones by H2-clearance method. CVR was evaluated as a ratio: cerebral blood flow after 7% CO2 inhalation to initial level. This ratio, or reactivity coefficient (RC), in normal conditions is 1.49-1.59. Nimodipine in dose 0.01 mg/kg resulted in significant decrease (by 15-20%) of RC only in cortex. In dose 0.06 mg/kg this decreased RC was about 20-30% in cortex and in hypothalamus, but in thalamus the changes of RC were insignificant. Verapamil in dose 0.6 mg/kg resulted in different changes of RC: increase in cortex, decrease in thalamus, but in hypothalamus no changes. In dose 1.0 mg/kg RC was decreased in cortex by 15-20%, in other zones were no changes.
在12只家兔的慢性实验中,研究了钙拮抗剂尼莫地平(静脉注射0.01和0.06mg/kg)和维拉帕米(静脉注射0.6和1.0mg/kg)对脑血管反应性(CVR)的影响。将铂电极植入皮层、丘脑和下丘脑,并用H2清除法测量这些区域的脑血流量。CVR以吸入7%二氧化碳后的脑血流量与初始水平的比值来评估。该比值,即反应系数(RC),在正常情况下为1.49-1.59。0.01mg/kg剂量的尼莫地平仅使皮层的RC显著降低(降低15-20%)。0.06mg/kg剂量时,皮层和下丘脑的RC降低约20-30%,但丘脑的RC变化不显著。0.6mg/kg剂量的维拉帕米导致RC出现不同变化:皮层增加,丘脑降低,而下丘脑无变化。1.0mg/kg剂量时,皮层的RC降低15-20%,其他区域无变化。